Trends in Caffeine Use and Association between Clinical Outcomes and Timing of Therapy in Very Low Birth Weight Infants - 16/04/14
, Devon R. Kuehn, MD 4, Jennifer Clark, PhD 5, Shilpa Vyas-Read, MD 2, Amy Herring, ScD 5, Matthew M. Laughon, MD, MPH 6, David Carlton, MD 2, Carl E. Hunt, MD 1Abstract |
Objective |
To examine the effect of early initiation of caffeine therapy on neonatal outcomes and characterize the use of caffeine therapy in very low birth weight (VLBW) infants.
Study design |
We analyzed a cohort of 62 056 VLBW infants discharged between 1997 and 2010 who received caffeine therapy. We compared outcomes in infants receiving early caffeine therapy (initial dose before 3 days of life) and those receiving late caffeine therapy (initial dose at or after 3 days of life) through propensity scoring using baseline and early clinical variables. The primary outcome was the association between the timing of caffeine initiation and the incidence of bronchopulmonary dysplasia (BPD) or death.
Results |
We propensity score–matched 29 070 VLBW infants at a 1:1. Of infants receiving early caffeine therapy, 3681 (27.6%) died or developed BPD, compared with 4591 infants (34.0%) receiving late caffeine therapy (OR, 0.74; 99% CI, 0.69-0.80). Infants receiving early caffeine had a lower incidence of BPD (23.1% vs 30.7%; OR, 0.68; 95% CI, 0.63-0.73) and a higher incidence of death (4.5% vs 3.7%; OR, 1.23; 95% CI, 1.05-1.43). Infants receiving early caffeine therapy had less treatment of patent ductus arteriosus (OR, 0.60; 95% CI, 0.55-0.65) and a shorter duration of mechanical ventilation (mean difference, 6 days; P < .001).
Conclusion |
Early caffeine initiation is associated with a decreased incidence of BPD. Randomized trials are needed to determine the efficacy and safety of early caffeine prophylaxis in VLBW infants.
Le texte complet de cet article est disponible en PDF.Keyword : BPD, CAP, CPAP, DOL, GA, FiO2, HFOV, IVH, MV, NEC, PDA, PS, ROP, VLBW
Plan
| Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000454 and KL2TR000455 to R.P.) and the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (HHSN267200700051C, HHSN275201000003I, and 1K23HL092225-01), the American Recovery and Reinvestment Act (1R18AE000028-01 to P.S.), and the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH; UL1TR001117). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Army, Department of Defense, US government, or NIH. The authors declare no conflicts of interest. |
Vol 164 - N° 5
P. 992 - mai 2014 Retour au numéro
Article précédent
- Hypotension in Preterm Neonates: Low Blood Pressure Alone Does Not Affect Neurodevelopmental Outcome
- Thomas Alderliesten, Petra M.A. Lemmers, Ingrid C. van Haastert, Linda S. de Vries, Hilde J.C. Bonestroo, Willem Baerts, Frank van Bel
- Preferential Cephalic Redistribution of Left Ventricular Cardiac Output during Therapeutic Hypothermia for Perinatal Hypoxic-Ischemic Encephalopathy
- Ori Hochwald, Mohammad Jabr, Horacio Osiovich, Steven P. Miller, Patrick J. McNamara, Pascal M. Lavoie
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?